Efficacy of the investigational mTOR kinase inhibitor MLN0128 / INK128 in models of B-cell acute lymphoblastic leukemia

The mechanistic target of rapamycin (mTOR) is a serine/threonine kinase whose activity contributes to leukemia proliferation and survival. Compounds targeting the mTOR active site inhibit rapamycin-resistant functions and have enhanced anti-cancer activity in mouse models. MLN0128 (formerly known as...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Janes, Matthew R., Vu, Collin, Mallya, Sharmila, Shieh, Marie, Limon, Jose J., Li, Lian-Sheng, Jessen, Katti A., Martin, Michael B., Ren, Pingda, Lilly, Michael B., Sender, Leonard, Liu, Yi, Rommel, Christian, Fruman, David A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3593948/
https://ncbi.nlm.nih.gov/pubmed/23090679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2012.276
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados